As part of RareCan's new Trial Matching service our team are having lots of conversations with people with rare and less common types of cancer about phase 1 trials. (As well as about later phase trials...) Coming from a non cancer background, I used to think of phase 1 trials only involving healthy volunteers. Here our Chief Scientific Officer Andy Hall talks about why phase 1 cancer trials involve patients. #cancer #cancerresearch #clinicaltrials
Our Chief Scientific Officer, Andy Hall is happy to answer questions from members within our community. This week his focus is on Phase 1 trials and why join them? You can read a short summary on what a phase 1 trial is, and why they are so important ➡️ https://bit.ly/49iJ8LH